Catalent is moving further and faster with its global expansion plans while building its softgel and nutritional product capacity. The contract manufacturer will move into Brazil with the acquisition of Relthy Laboratórios.
The product has been approved in Ireland, the Netherlands, Sweden and the U.K., but the company said Thursday that Swissmedic had turned down the drug.
It looks like a national track and trace system is going to be implemented in the U.S. sooner rather than later. Differences between what industry believes it is capable of handling and what regulators believe it must kept it out of the FDA reauthorization bill, but no one should think that put it into the deep freeze.
Federal authorities have taken down another player in the escalating counterfeit drug trade, this one for shipping foreign-made cold chain cancer drugs that arrived at a doctor's office as a "gooey mess."
Roche ($RHHBY) Diagnostics has reportedly begun a cold-chain-equipped direct flight each weekend from Indianapolis to Luxembourg. The move lets the drugmaker skip a stop in Chicago--European...